FDA patent application, new warrant excercise at 0.10cYesterday, VXL announced that a further $221,000 has been received from the exercise of 2.21 million warrants, having an exercise price of $0.10 per warrant, that were previously issued in January 2018. Upon exercise of the warrants an additional 2.22 million common shares of the company will be issued.
Probably, this is keeping stock down for a bit but once they get something from FDA on their recent CV patent, it will fly.